VEGFA and cancer: Similar to Panc-1 cells, breast (MDA-MB-231), cervical (HeLa), colorectal (DLD-1), esophageal (T.T) and tongue (HSC3) cancer cell lines treated with non-toxic doses of TD-10 and TD-11 (Figure S1) showed a significant delay in cell migration (Figure S2), and a decrease in VEGF and MMPs protein expression (Figures S3 and S4).